We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03755518
Brief Title: A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM)

First Submitted : November 8, 2018
First Submitted that Met QC Criteria : November 26, 2018
First Posted : November 28, 2018

Results First Submitted : November 22, 2022
Results First Posted with QC Comments : December 20, 2022
Results First Submitted that Met QC Criteria : February 13, 2023
Results First Posted : March 9, 2023

Last Update Submitted that Met QC Criteria : February 13, 2023
Last Update Posted : March 9, 2023